Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on April 29, 2021, primarily to report its first-quarter 2021 financial results. The filing includes a press release detailing these results, supplemental information, and a presentation used during their earnings call. Investors should review these materials for a comprehensive understanding of the company's performance during the quarter, including any key operational or financial initiatives discussed. While the 8-K itself doesn't contain the detailed financial figures, it directs investors to the furnished exhibits (press release, supplemental information, and presentation) for this crucial data. These documents are essential for assessing BMY's financial health, revenue drivers, and strategic direction as communicated by the company on April 29, 2021.
Key Highlights
- 1BMY announced its first-quarter 2021 financial results via an earnings press release filed with the SEC.
- 2The company also provided supplemental financial information and a presentation on its website, both furnished as exhibits.
- 3These documents were made available on April 29, 2021, in conjunction with the company's earnings call and webcast.
- 4Investors can find detailed financial and operational insights within the furnished exhibits (Exhibit 99.1, 99.2, and 99.3).
- 5The filing includes references to non-GAAP financial information, with reconciliations provided in the supplemental materials.
- 6The materials furnished under Item 7.01 are not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, limiting liability.